These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

100 related items for PubMed ID: 15993985

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T, Kiliaan AJ, Kadish I.
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [Abstract] [Full Text] [Related]

  • 4. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
    Liu L, Ikonen S, Heikkinen T, Tapiola T, van Groen T, Tanila H.
    Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883
    [Abstract] [Full Text] [Related]

  • 5. Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice.
    Malm TM, Koistinaho M, Pärepalo M, Vatanen T, Ooka A, Karlsson S, Koistinaho J.
    Neurobiol Dis; 2005 Feb; 18(1):134-42. PubMed ID: 15649704
    [Abstract] [Full Text] [Related]

  • 6. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease.
    El Tannir El Tayara N, Delatour B, Le Cudennec C, Guégan M, Volk A, Dhenain M.
    Neurobiol Dis; 2006 Apr; 22(1):199-208. PubMed ID: 16337798
    [Abstract] [Full Text] [Related]

  • 7. Cortical plasticity in Alzheimer's disease in humans and rodents.
    Battaglia F, Wang HY, Ghilardi MF, Gashi E, Quartarone A, Friedman E, Nixon RA.
    Biol Psychiatry; 2007 Dec 15; 62(12):1405-12. PubMed ID: 17651702
    [Abstract] [Full Text] [Related]

  • 8. Presenilin 1-related alterations in DNA integrity in a transgenic mouse model of Alzheimer's disease.
    Michelsen KA, Korr H, Steinbusch HW, Schmitz C.
    Brain Res; 2010 Feb 26; 1316():139-44. PubMed ID: 20034479
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early temporal short-term memory deficits in double transgenic APP/PS1 mice.
    Lagadec S, Rotureau L, Hémar A, Macrez N, Delcasso S, Jeantet Y, Cho YH.
    Neurobiol Aging; 2012 Jan 26; 33(1):203.e1-11. PubMed ID: 20817351
    [Abstract] [Full Text] [Related]

  • 12. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J, Luo H, Yan B, Yu Y, Wang H, Wei Z, Zhang Y, Xu H, Tempier A, Li X, Li XM.
    Neurobiol Aging; 2009 Aug 26; 30(8):1205-16. PubMed ID: 18079026
    [Abstract] [Full Text] [Related]

  • 13. An in vitro and in vivo study of early deficits in associative learning in transgenic mice that over-express a mutant form of human APP associated with Alzheimer's disease.
    Domínguez-del-Toro E, Rodríguez-Moreno A, Porras-García E, Sánchez-Campusano R, Blanchard V, Laville M, Böhme GA, Benavides J, Delgado-García JM.
    Eur J Neurosci; 2004 Oct 26; 20(7):1945-52. PubMed ID: 15380017
    [Abstract] [Full Text] [Related]

  • 14. Selective improvement of cognitive function in adult and aged APP/PS1 transgenic mice by continuous non-shock treadmill exercise.
    Ke HC, Huang HJ, Liang KC, Hsieh-Li HM.
    Brain Res; 2011 Jul 27; 1403():1-11. PubMed ID: 21689809
    [Abstract] [Full Text] [Related]

  • 15. Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease.
    Boissonneault V, Filali M, Lessard M, Relton J, Wong G, Rivest S.
    Brain; 2009 Apr 27; 132(Pt 4):1078-92. PubMed ID: 19151372
    [Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics and amyloid plaque targeting ability of a novel peptide-based magnetic resonance contrast agent in wild-type and Alzheimer's disease transgenic mice.
    Kandimalla KK, Wengenack TM, Curran GL, Gilles EJ, Poduslo JF.
    J Pharmacol Exp Ther; 2007 Aug 27; 322(2):541-9. PubMed ID: 17505020
    [Abstract] [Full Text] [Related]

  • 17. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB, Franko M, Banks WA, Kasinadhuni P, Farr SA, Vyas K, Choudhuri V, Morley JE.
    J Exp Biol; 2009 Feb 27; 212(Pt 4):494-8. PubMed ID: 19181896
    [Abstract] [Full Text] [Related]

  • 18. Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP + PS1 transgenic mouse brains.
    Amritraj A, Hawkes C, Phinney AL, Mount HT, Scott CD, Westaway D, Kar S.
    Neurobiol Aging; 2009 Jan 27; 30(1):54-70. PubMed ID: 17561313
    [Abstract] [Full Text] [Related]

  • 19. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
    Pardon MC, Sarmad S, Rattray I, Bates TE, Scullion GA, Marsden CA, Barrett DA, Lowe J, Kendall DA.
    Neurobiol Aging; 2009 Jul 27; 30(7):1099-113. PubMed ID: 18023506
    [Abstract] [Full Text] [Related]

  • 20. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy.
    Miettinen R, Riedel A, Kalesnykas G, Kettunen HP, Puoliväli J, Soininen H, Arendt T.
    J Chem Neuroanat; 2005 Oct 27; 30(2-3):105-18. PubMed ID: 16081247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.